Dibyendu Sarkar

Dibyendu Sarkar is an Indian biochemist, molecular microbiologist and a senior principal scientist at the Institute of Microbial Technology.[1] He is known for his studies on Mycobacterium tuberculosis (Mtb), the bacterial pathogen causing the disease of tuberculosis.[2] His studies have been documented by way of a number of articles[note 1] and Google Scholar, an online repository of scientific articles has listed 23 of them.[3] He has also delivered invited speeches which included the Second Annual Meeting on Infectious Diseases held at the Indian Institute of Science in September 2017.[4] He is an elected member of Guha Research Conference and a recipient of the Raman Research Fellowship of the Council of Scientific and Industrial Research .[5] The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2011.[6]

Dibyendu Sarkar
Born
India
NationalityIndian
Known forStudies on Mycobacterium tuberculosis
Awards
Scientific career
Fields
Institutions

Selected bibliography
  • Bansal, Roohi; Anil Kumar, Vijjamarri; Sevalkar, Ritesh Rajesh; Singh, Prabhat Ranjan; Sarkar, Dibyendu (1 May 2017). "Mycobacterium tuberculosis virulence-regulator PhoP interacts with alternative sigma factor SigE during acid-stress response". Molecular Microbiology. 104 (3): 400–411. doi:10.1111/mmi.13635. ISSN 1365-2958. PMID 28142206.
  • Sebastian Samuel, Jesse; Kumar, Deepak; Chodisetti, Sathi Babu; Agrewala, Javed N.; Singh, Balvinder; Guptasarma, Purnananda; Sarkar, Dibyendu (1 October 2015). "Probing protease sensitivity of recombinant human erythropoietin reveals α3–α4 inter-helical loop as a stability determinant". Proteins: Structure, Function, and Bioinformatics. 83 (10): 1813–1822. doi:10.1002/prot.24865. ISSN 1097-0134. PMID 26214268.
  • Gupta, Sankalp; Pathak, Anuj; Sinha, Akesh; Sarkar, Dibyendu (15 December 2009). "Mycobacterium tuberculosis PhoP Recognizes Two Adjacent Direct-Repeat Sequences To Form Head-to-Head Dimers". Journal of Bacteriology. 191 (24): 7466–7476. doi:10.1128/jb.00669-09. ISSN 0021-9193. PMC 2786591. PMID 19820095.
gollark: - it funds the BBC, but you have to pay it if you watch *any* live TV, or watch BBC content online- it's per property, not per person, so if you have a license, and go somewhere without a license, and watch TV on some of your stuff, you are breaking the law (unless your thing is running entirely on battery power and not mains-connected?)- it costs about twice as much as online subscription service things- there are still black and white licenses which cost a third of the price
gollark: Very unrelated to anything, but I recently read about how TV licensing works in the UK and it's extremely weird.
gollark: "I support an increase in good things and a reduction in bad things"
gollark: Or maybe they just check it for keywords automatically, who knows.
gollark: I assume most people would agree with (most of) those things, but just saying, effectively, "more good things, fewer bad things" isn't very meaningful. Maybe that's what you're going for, but I assume they might want you to say/make up more personal-scale things.

See also

Notes
  1. Please see Selected bibliography section

References
  1. "Dibyendu Sarkar on Imtech". Institute of Microbial Technology. 30 January 2018. Retrieved 30 January 2018.
  2. "Research and development interests". Imtech. 30 January 2018. Retrieved 30 January 2018.
  3. "On Google Scholar". Google Scholar. 30 January 2018. Retrieved 30 January 2018.
  4. "Second Annual Meeting on Infectious Diseases" (PDF). Indian Institute of Science. 2017. Retrieved 30 January 2018.
  5. "Raman Research Fellowship" (PDF). www.csir.res.in/sites/default/files/RamanResearch2013-14.pdf. 30 January 2018. Retrieved 30 January 2018.
  6. "Awardees of National Bioscience Awards for Career Development" (PDF). Department of Biotechnology. 2016. Retrieved 20 November 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.